We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHG icon
201
Philips
PHG
$26.2B
$845M 0.11%
45,901,909
+4,711,908
+11% +$102M
HBAN icon
202
Huntington Bancshares
HBAN
$36.1B
$833M 0.11%
69,263,384
+5,592,181
+9% +$74.2M
HCA icon
203
HCA Healthcare
HCA
$89.8B
$832M 0.11%
4,951,222
-10,123,663
-67% -$2.17B
AMAT icon
204
Applied Materials
AMAT
$435B
$830M 0.1%
9,122,174
+154,413
+2% +$16.9M
ENTG icon
205
Entegris
ENTG
$24.6B
$820M 0.1%
8,905,405
-229,973
-3% -$24.9M
CMS icon
206
CMS Energy
CMS
$22B
$818M 0.1%
12,119,031
-4,990,345
-29% -$345M
BFAM icon
207
Bright Horizons
BFAM
$3.76B
$815M 0.1%
9,643,500
+864,487
+10% +$85.9M
DUK icon
208
Duke Energy
DUK
$96.3B
$811M 0.1%
7,566,436
+6,387,550
+542% +$702M
NI icon
209
NiSource
NI
$20.1B
$803M 0.1%
27,245,143
-2,929,672
-10% -$88.7M
DSGX icon
210
Descartes Systems
DSGX
$6.65B
$799M 0.1%
12,874,995
+2,261,747
+21% +$141M
KKR icon
211
KKR & Co
KKR
$99.5B
$795M 0.1%
17,175,960
-577,548
-3% -$30.3M
CRWD icon
212
CrowdStrike
CRWD
$226B
$783M 0.1%
18,569,864
+2,773,996
+18% +$126M
XYZ
213
Block Inc
XYZ
$47B
$781M 0.1%
12,702,025
+686,870
+6% +$62.8M
KEYS icon
214
Keysight
KEYS
$60.6B
$771M 0.1%
5,595,608
-73,905
-1% -$10.5M
CSCO icon
215
Cisco
CSCO
$488B
$763M 0.1%
17,897,762
-507,911
-3% -$24.3M
MKTX icon
216
MarketAxess Holdings
MKTX
$5.72B
$763M 0.1%
2,980,648
-726,700
-20% -$199M
C icon
217
Citigroup
C
$231B
$762M 0.1%
16,565,095
+526,282
+3% +$26.3M
EFX icon
218
Equifax
EFX
$21.2B
$760M 0.1%
4,160,261
+949,408
+30% +$190M
WELL icon
219
Welltower
WELL
$166B
$760M 0.1%
9,231,883
-565,686
-6% -$50.3M
PODD icon
220
Insulet
PODD
$10.1B
$756M 0.1%
3,467,820
-24,892
-0.7% -$5.66M
EL icon
221
Estee Lauder
EL
$31.7B
$749M 0.09%
2,939,702
+316,211
+12% +$80.2M
RBLX icon
222
Roblox
RBLX
$25.4B
$748M 0.09%
22,770,208
-1,303,045
-5% -$43.8M
QDEL icon
223
QuidelOrtho
QDEL
$1.02B
$743M 0.09%
7,645,281
+1,477,985
+24% +$151M
SLF icon
224
Sun Life Financial
SLF
$44.4B
$733M 0.09%
16,021,837
-1,516,005
-9% -$75.5M
CMI icon
225
Cummins
CMI
$87.8B
$727M 0.09%
3,756,212
+691,053
+23% +$138M

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.